B. Szathmáry

Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study

G. Lippi, Z. Prohászka, L. Cervenak, 2022, Frontiers in Medicine.

Role of favipiravir in the treatment of adult patients with moderate to severe COVID-19: a single-center, prospective, observational, sequential cohort study from Hungary

Z. Banyai, J. Szlávik, B. Szabo, 2020, medRxiv.

Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection

Z. Prohászka, L. Cervenak, T. Masszi, 2021, Frontiers in Immunology.

Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups

P. Lyons, Á. Szilágyi, Z. Prohászka, 2023, Frontiers in Immunology.

Associations between the von Willebrand Factor—ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality

Z. Prohászka, L. Cervenak, T. Masszi, 2022, Thrombosis and haemostasis.